Letter to Congress Offering Health Care-Related Reforms for Possible Inclusion in Future Cures 2.0 Legislation December 16, 2019
Letter to the FDA Urging the Agency Not to Approve the De Novo Premarket Application for neuroAD Therapy System for the Treatment of Alzheimer’s Dementia April 9, 2019
Testimony Before the FDA’s General and Plastic Surgery Devices Panel Regarding Breast Implants March 26, 2019
Testimony Before the FDA’s Obstetrics and Gynecology Devices Panel Regarding Surgical Mesh for Transvaginal Repair of Pelvic Organ Prolapse February 12, 2019
Comments on the FDA’s Proposed Voluntary Malfunction Summary Reporting Program for Manufacturers February 26, 2018
Letter to Congress Opposing Legislation That Would Expand Promotion of Drugs for Unapproved Uses January 16, 2018
Letter to Congress Opposing Legislation That Would Provide False Hope to Terminally Ill Patients August 2, 2017
Letter to Congress Opposing Draft Legislation That Would Expand Promotion of Medical Products for Unapproved Uses July 11, 2017
Letter to Congress Opposing Legislation That Would Expand Promotion of Medical Products for Unapproved Uses June 5, 2017